Last Month we had:
Goldman Analyst Downgrades J&J: Says "Sell"
and now comes:
Seeking Alpha with;
J&J: Litigation Makes This Pharma A Pass in 2013
"Johnson & Johnson (JNJ) engages in the research and development, manufacture, and sale of various products in the health care field worldwide. JNJ's headquarters is in New Brunswick, New Jersey. The company has a market cap of $191.7 billion, and its stock price is around $70.